Advertisement
Screener

Co-Diagnostics, Inc. (CODX) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount

2.8 / 5 stars · 68/120 Roast Me

Co-Diagnostics, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount

Co-Diagnostics, Inc. (CODX) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 0 shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.

Financial Statements › Income Statement › Earnings Per Share

us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-13

  • Co-Diagnostics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 0.00 shares.
  • Co-Diagnostics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 0.00 shares.
  • Co-Diagnostics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 0.00 shares.
  • Co-Diagnostics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 0.00 shares.
  • Co-Diagnostics, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 0.00 shares.
  • Co-Diagnostics, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 0.00 shares.
  • Co-Diagnostics, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 0.00 shares.
  • Co-Diagnostics, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 0.00 shares, a 100.00% decline from fiscal 2021.
Period endAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filedAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filedAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month
2026-06-300.00 shares
10-Q · filed 2026-08-13
0.00 shares
10-Q · filed 2026-08-13
2026-03-310.00 shares
10-Q · filed 2026-05-14
2025-12-310.00 shares
10-K · filed 2026-03-31
2025-09-300.00 shares
10-Q · filed 2025-11-13
0.00 shares
10-Q · filed 2025-11-13
2025-06-300.00 shares
10-Q · filed 2026-08-13
0.00 shares
10-Q · filed 2026-08-13
2025-03-310.00 shares
10-Q · filed 2026-05-14
2024-12-310.00 shares
10-K · filed 2026-03-31
2024-09-300.00 shares
10-Q · filed 2025-11-13
0.00 shares
10-Q · filed 2025-11-13
2024-06-300.00 shares
10-Q · filed 2025-08-14
0.00 shares
10-Q · filed 2025-08-14
2024-03-310.00 shares
10-Q · filed 2025-05-08
2023-12-310.00 shares
10-K · filed 2025-03-27
2023-09-300.00 shares
10-Q · filed 2024-11-07
0.00 shares
10-Q · filed 2024-11-07
2023-06-300.00 shares
10-Q · filed 2024-08-08
0.00 shares
10-Q · filed 2024-08-08
2023-03-310.00 shares
10-Q · filed 2024-05-09
2022-12-310.00 shares
10-K · filed 2024-03-14
2022-09-302.63M shares
10-Q · filed 2023-11-09
1.39M shares
10-Q · filed 2023-11-09
2022-06-301.39M shares
10-Q · filed 2023-08-10
1.16M shares
10-Q · filed 2023-08-10
2022-03-311.27M shares
10-Q · filed 2023-05-11
2021-12-31154.64K shares
10-K · filed 2023-03-16
2021-09-3050.00K shares
10-Q · filed 2022-11-10
147.44K shares
10-Q · filed 2022-11-10
2021-06-30931.34K shares
10-Q · filed 2022-08-11
146.13K shares
10-Q · filed 2022-08-11
2021-03-312.32M shares
10-Q · filed 2022-05-12
2020-12-3150.00K shares
10-K · filed 2022-03-24
2020-09-3050.00K shares
10-Q · filed 2021-11-12
50.00K shares
10-Q · filed 2021-11-12
2020-06-300.00 shares
10-Q · filed 2021-08-12
0.00 shares
10-Q · filed 2021-08-12
2020-03-312.32M shares
10-Q · filed 2020-05-14
2019-12-313.01M shares
10-K · filed 2020-03-30
2019-09-305.11M shares
10-Q · filed 2019-11-12
5.11M shares
10-Q · filed 2019-11-12
2019-06-304.53M shares
10-Q/A · filed 2020-11-03
2.22M shares
10-Q · filed 2019-08-14
4.53M shares
10-Q/A · filed 2020-11-03
2.22M shares
10-Q · filed 2019-08-14
2019-03-311.68M shares
10-Q · filed 2020-05-14
2018-12-311.66M shares
10-K · filed 2020-03-30
2018-09-301.61M shares
10-Q · filed 2019-11-12
1.61M shares
10-Q · filed 2019-11-12
2018-06-301.03M shares
10-Q · filed 2019-08-14
1.03M shares
10-Q · filed 2019-08-14
2018-03-311.03M shares
10-Q · filed 2019-05-14
2017-12-311.03M shares
10-K · filed 2019-04-01
2017-09-301.03M shares
10-Q · filed 2018-11-14
1.03M shares
10-Q · filed 2018-11-14
2017-06-303.53M shares
10-Q · filed 2018-08-10
3.53M shares
10-Q · filed 2018-08-10

Similar stocks

Stock NameCountryMarket CapPE Ratio
enVVeno Medical Corp (NVNO)United States$0.006B-0.48
Sonoma Pharmaceuticals, Inc. (SNOA)United States$0.006B-2.59
INTELLIGENT BIO SOLUTIONS INC. (INBS)United States$0.005B
AETHLON MEDICAL INC (AEMD)United States$0.005B
Bluejay Diagnostics, Inc. (BJDX)United States$0.004B
OSR Health, Inc. (OSRH)United States$0.004B-0.75
Adagio Medical Holdings, Inc. (ADGM)United States$0.004B
ALLURION TECHNOLOGIES, INC. (ALUR)United States$0.010B
Autonomix Medical, Inc. (AMIX)United States$0.004B
Picard Medical, Inc. (PMI)United States$0.011B-0.01